MedTrace Logo

Hyaluronan in the Treatment of Painful Achilles Tendinopathy.

NCT01954108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2015-11-09

No results posted yet for this study

Summary

The primary objective of this study is to compare OSTENIL® TENDON (2% hyaluronan) and Extracorporeal Shock Wave (ESWT) therapy in the treatment of painful Achilles tendinopathy.

Conditions

  • Tendinopathy

Interventions

DEVICE

hyaluronic acid sodium salt

DEVICE

ESWT

Sponsors & Collaborators

  • TRB Chemedica AG

    lead INDUSTRY

Principal Investigators

  • Thierry De Vroey, Dr. med. · Universitair Ziekenhuis Antwerpen, Fysische Geneeskunde en Revalidatie

  • Nils Lynen, Dr. med. · Praxiszentrum Orthopädie-Unfallchirurgie Nordrhein

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-07-31
Completion
2015-10-31

Countries

  • Belgium
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01954108 on ClinicalTrials.gov